WIL Research Acquires Ricerca Facility in Lyon, France|
Friday, June 21, 2013
The addition of the 18,000-square meter facility fortifies WIL Research’s service offerings in Europe.
RIFM Adopts BlueScreen HC™ for Early Genetic Toxicology Screening of Fragrance Materials
Wednesday, June 19, 2013
As part of its continuing mission to ensure the safety of fragrance ingredients, the RIFM has incorporated early screening with BlueScreen™ into its genotoxicity profiling regime.
Spicing Up Fingerprints
Thursday, June 06, 2013
New findings suggests that turmeric could be used to help solve crimes.
Agilent to Host Forensics Webinar
Wednesday, June 05, 2013
The webinar, which will be held on June 20, will focus on LC/MS/MS methods for cannabinoid and benzodiazepine quantitation in whole blood samples.
Researchers Identify Novel Class of Drugs for Prostate Cancers
Wednesday, May 29, 2013
A new study on prostate cancer describes a novel class of drugs that interrupts critical signaling needed for prostate cancer cells to grow.
CytRx Announces Initial Results from PK Clinical Trial with Aldoxorubicin
Wednesday, May 22, 2013
Aldoxorubicin shows prolonged clinical activity in two clinical trial patients with small cell lung cancer who have failed other therapies.
Hurel Corporation Makes New Appointment to Board
Tuesday, May 21, 2013
Leading pharmaceutical executive and toxicologist Dr. James S. MacDonald appointed to Board of Directors.
Thermo Scientific at ASMS 2013
Monday, May 13, 2013
Learn how scientists and researchers are transforming science by applying innovative solutions to a wide range of qualitative and quantitative applications.
Aileron Therapeutics Successfully Completes First-Ever Stapled Peptide Clinical Trial
Thursday, May 09, 2013
Safety and pharmacokinetics of ALRN-5281, a long-acting growth-hormone-releasing-hormone agonist, established in single-ascending dose study.